phenobarbital has been researched along with procainamide in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (54.55) | 18.7374 |
1990's | 1 (3.03) | 18.2507 |
2000's | 7 (21.21) | 29.6817 |
2010's | 7 (21.21) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Sen, S; Sinha, N | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Harner, RS; McDowell, AE; Pardue, HL | 1 |
Freeman, RW; Harbison, RD; Oates, JA; Woosley, RL | 1 |
Eaton, DL; Klaassen, CD | 1 |
Briggs, WA; Gibson, TP; Matusik, E; Nelson, LD | 1 |
Reidenberg, MM | 1 |
Pitterle, ME; Sorkness, CA; Wiederholt, JB | 1 |
Homola, D; Rotrekl, J; Srnová, V | 1 |
Enna, SJ; Schanker, LS | 1 |
Kobayashi, K | 1 |
Klaassen, CD | 1 |
Emig, W | 1 |
Grosser, KD; Humpert, U | 1 |
Akera, T; Brody, TM; Kondo, H; Temma, K | 1 |
Brouland, JP; Descotes, J; Patriarca, C; Verdier, F | 1 |
SCHMIDT-VOIGT, J | 1 |
KIMURA, E | 1 |
MACKENZIE, GJ; PASCUAL, S | 1 |
FOERSTER, K; KROETZ, C | 1 |
2 review(s) available for phenobarbital and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug metabolism in uremia.
Topics: Acetohexamide; Animals; Antipyrine; Humans; Hydrolysis; Lipid Metabolism; Microsomes, Liver; Oxidation-Reduction; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Procainamide; Rats; Tolbutamide; Uremia; Vitamin D | 1975 |
1 trial(s) available for phenobarbital and procainamide
Article | Year |
---|---|
[Use of Coritrate in the prevention of paroxysmal tachycardia].
Topics: Adult; Aged; Ajmaline; Cardiac Glycosides; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Meprobamate; Middle Aged; Phenobarbital; Procainamide; Quinidine; Tachycardia, Paroxysmal; Theophylline | 1973 |
30 other study(ies) available for phenobarbital and procainamide
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Application of a vidicon spectrometer for simultaneous multicomponent drug determinations.
Topics: Acetaminophen; Aminophylline; Barbiturates; Computers; Humans; Pharmaceutical Preparations; Phenobarbital; Phenylbutazone; Phenytoin; Procainamide; Regression Analysis; Salicylamides; Secobarbital; Spectrophotometry, Ultraviolet; Time Factors | 1976 |
Evidence for the biotransformation of procainamide to a reactive metabolite.
Topics: Acetylation; Animals; Biotransformation; Hydralazine; Male; Mice; Microsomes, Liver; NADP; Phenobarbital; Proadifen; Procainamide; Salmonella typhimurium | 1979 |
Effects of microsomal enzyme inducers on carrier-mediated transport systems in isolated rat hepatocytes.
Topics: Animals; Biological Transport, Active; Enzyme Induction; In Vitro Techniques; Kinetics; Liver; Male; Methylcholanthrene; Microsomes, Liver; Ouabain; Phenobarbital; Pregnenolone Carbonitrile; Procainamide; Rats; Taurocholic Acid | 1979 |
Artificial kidneys and clearance calculations.
Topics: Blood Flow Velocity; Humans; Kidneys, Artificial; Mathematics; Metabolic Clearance Rate; Pharmaceutical Preparations; Phenobarbital; Plasma; Procainamide; Quinidine; Renal Dialysis; Urea | 1976 |
Use of serum drug concentrations in outpatient clinics.
Topics: Carbamazepine; Digoxin; Humans; Medication Systems, Hospital; Outpatient Clinics, Hospital; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Procainamide; Quinidine; Theophylline; Wisconsin | 1985 |
Absorption of drugs from the rat lung.
Topics: Absorption; Aminohippuric Acids; Aniline Compounds; Animals; Antipyrine; Diffusion; Intestinal Absorption; Lung; Male; Pentobarbital; Permeability; Pharmaceutical Preparations; Phenobarbital; Procainamide; Pulmonary Alveoli; Rats; Salicylates; Sulfonic Acids; Tetraethylammonium Compounds | 1972 |
[Experimental studies on the mechanism of digitalis and several antiarrhythmic agents--a consideration on roles of the central nervous system].
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Brain; Cerebral Cortex; Digitalis Glycosides; Electrocardiography; Electroencephalography; Hypothalamus; Mesencephalon; Phenobarbital; Phenytoin; Procainamide; Propranolol; Rabbits; Thalamus | 1972 |
Effects of phenobarbital on the plasma disappearance and biliary excretion of drugs in rats.
Topics: Animals; Bile; Bile Acids and Salts; Bilirubin; Chlorothiazide; Coloring Agents; Indocyanine Green; Male; Ouabain; Phenobarbital; Phenols; Probenecid; Procainamide; Rats; Succinates; Sulfathiazoles; Sulfobromophthalein | 1970 |
[On the drug therapy of arrhytmias].
Topics: Arrhythmias, Cardiac; Humans; Meprobamate; Phenobarbital; Phytotherapy; Plants, Medicinal; Procainamide; Rauwolfia; Theophylline | 1966 |
[On the therapy of the combination form of Adams-Stokes syndrome with orciprenaline].
Topics: Adams-Stokes Syndrome; Aged; Bronchodilator Agents; Electric Countershock; Female; Humans; Meperidine; Metaproterenol; Phenethylamines; Phenobarbital; Phytotherapy; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Resorcinols; Ventricular Fibrillation | 1966 |
Positive inotropic action of p-chloromercuribenzoate in isolated guinea-pig heart: influence of membrane stabilizing agents.
Topics: Animals; Cell Membrane; Chloromercuribenzoates; Diphenhydramine; Drug Interactions; Ethylmaleimide; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Ouabain; p-Chloromercuribenzoic Acid; Phenobarbital; Procainamide; Propranolol; Stereoisomerism | 1981 |
Popliteal lymph node response to procainamide and isoniazid. Role of beta-naphthoflavone, phenobarbitone and S9-mix pretreatment.
Topics: Animals; Autoimmune Diseases; Benzoflavones; beta-Naphthoflavone; Biotransformation; Drug Evaluation, Preclinical; Enzyme Induction; Female; Isoniazid; Knee; Liver Extracts; Lymph Nodes; Male; Models, Biological; Phenobarbital; Procainamide; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Time Factors | 1993 |
[Extrasystolic heart rhythm disorders; practical viewpoints on diagnosis and therapy].
Topics: Arrhythmias, Cardiac; Humans; Phenobarbital; Plant Extracts; Procainamide; Quinidine; Vestibule, Labyrinth | 1958 |
[ARRHYTHMIA].
Topics: Adrenal Cortex Hormones; Arrhythmias, Cardiac; Atropine; Diagnosis, Differential; Ephedrine; Epinephrine; Heart Block; Humans; Isoproterenol; Phenobarbital; Procainamide; Quinidine; Reserpine; Tachycardia | 1963 |
PAROXYSMAL VENTRICULAR TACHYCARDIA.
Topics: Coronary Disease; Diagnosis; Digitalis Glycosides; Electrocardiography; Heart Failure; Hydrocortisone; Morphine; Mortality; Myocardial Infarction; Phenobarbital; Procainamide; Quinidine; Rheumatic Heart Disease; Statistics as Topic; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular; Toxicology | 1964 |
[ANTI-ARRHYTHMIC SUBSTANCES IN THE TREATMENT OF THE HEART].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Drug Therapy; Heart; Humans; Meprobamate; Phenobarbital; Procainamide; Quinidine; Rauwolfia; Tachycardia; Tachycardia, Paroxysmal; Theophylline; Ventricular Fibrillation | 1965 |